Table 5.
Clinical outcomes | Without diabetes (n=2008, 57.4% of 3501 participants) (a) |
Newly diagnosed diabetes (n=508, 14.5% of 3501 participants) (b) |
Established diabetes (n=985, 28.1% of 3501 participants) (c) |
P value* (b) vs (a) |
P value† (b) vs (c) |
Mortality | |||||
In-hospital mortality | 1 (0.1%) | 0 | 3 (0.3%) | 0.555 | 0.999 |
30-day mortality | 12 (0.6%) | 0 | 9 (0.9%) | 0.026 | 0.011 |
1-year mortality | 32 (1.6%) | 5 (0.9%) | 35 (3.6%) | 0.0009 | 0.015 |
In-hospital medical complications | |||||
Re-infarction | 28 (1.4%) | 6 (1.2%) | 9 (0.9%) | 0.403 | 0.927 |
Heart failure | 109 (5.4%) | 36 (7.1%) | 97 (9.9%) | 0.176 | 0.214 |
Cardiac arrhythmias | 151 (7.5%) | 32 (6.3%) | 65 (6.6%) | 0.522 | 0.607 |
Stroke/Transient ischaemic attack | 6 (0.3%) | 2 (0.4%) | 4 (0.4%) | 0.892 | 0.912 |
Haemorrhagic complications | 153 (7.6%) | 38 (7.5%) | 80 (8.1%) | 0.489 | 0.921 |
P value numbers in bold denote statistical significance at the p<0.05 level.
*Unadjusted p values were testing for clinical outcomes differences between patients with newly diagnosed and no diabetes. Fisher’s exact for cells<5.
†Unadjusted p values were testing for clinical outcomes differences between patients with newly diagnosed and established diabetes. Fisher’s exact test for cells<5.
AMI, acute myocardial infarction.